Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human,Mouse,Rat |
Host species | Rabbit |
Applications | ELISA,IHC,WB-Ce |
Brand: | Abnova |
Reference: | PAB9992 |
Product name: | MET (phospho Y1349/1356) polyclonal antibody |
Product description: | Rabbit polyclonal antibody raised against synthetic phosphopeptide of MET. |
Gene id: | 4233 |
Gene name: | MET |
Gene alias: | AUTS9|HGFR|RCCP2|c-Met |
Gene description: | met proto-oncogene (hepatocyte growth factor receptor) |
Immunogen: | Synthetic phosphopeptide corresponding to residues surrounding Y1349/Y1356 of human MET. |
Protein accession: | NP_000236;P08581 |
Form: | Liquid |
Recommend dilutions: | ELISA (1:450000) Western Blot (1:500-1:2000) The optimal working dilution should be determined by the end user. |
Storage buffer: | In 20 mM KH2PO4, 150 mM NaCl, pH 7.2 (0.01% sodium azide) |
Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Rabbit |
Antigen species / target species: | Human |
Specificity: | This antibody is specific to human c-Met protein phosphorylated at Y1349 and Y1356. |
Reactivity: | Human,Mouse,Rat |
Application image: | ![]() |
Application image note: | Western blot using MET (phospho Y1349/1356) polyclonal antibody (Cat # PAB9992) shows detection of phosphorylated MET. Human mammary B5/589 epithelial cells were serum-deprived and treated with or without HGF. Cell lysates were immunoprecipated with the anti-MET antibody, resolved by SDS-PAGE, transferred to PVDF membrane, and probed with MET (phospho Y1349/1356) polyclonal antibody (Cat # PAB9992). Personal communication, D. Bottaro and T. Ito, NCI, Bethesda, MD. |
Applications: | ELISA,IHC,WB-Ce |
Shipping condition: | Dry Ice |
Publications: | Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene.Longati P, Comoglio PM, Bardelli A. Curr Drug Targets. 2001 Mar;2(1):41-55. |